Growth Metrics

Akari Therapeutics (AKTX) Cash & Equivalents Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -68.22%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 988.88%
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.00%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 15.64%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 4.77%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 17.50%
7 Evaxion A 62.56 Bn 62.54 Bn - 3.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -4.13%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 67.78%
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.77%
Dec 31, 2025 95.68%
Sep 30, 2025 -92.76%
Jun 30, 2025 -35.10%
Mar 31, 2025 97.10%
Dec 31, 2024 -32.41%
Jun 30, 2024 -68.48%
Dec 31, 2023 -70.98%
Jun 30, 2023 62.55%
Dec 31, 2022 142,082.64%
Jun 30, 2022 -42.01%
Mar 31, 2022 150.78%
Dec 31, 2021 -100.00%
Sep 30, 2021 8.71%
Jun 30, 2021 10.27%
Mar 31, 2021 -14.75%
Dec 31, 2020 99,900.00%
Sep 30, 2020 106.40%
Jun 30, 2020 365.76%
Mar 31, 2020 31.07%
Dec 31, 2019 -3.35%
Sep 30, 2019 -40.75%
Jun 30, 2019 -81.84%
Mar 31, 2019 -74.90%
Dec 31, 2018 -78.96%
Sep 30, 2018 -51.97%
Jun 30, 2018 -55.81%
Mar 31, 2018 -30.26%
Dec 31, 2017 -17.61%
Sep 30, 2017 -69.57%
Jun 30, 2017 -50.52%
Mar 31, 2017 -44.49%
Dec 31, 2016 -50.50%
Sep 30, 2016 1,971.24%
Jun 30, 2016 1,971.24%
Mar 31, 2016 4,523.41%
Dec 31, 2015 1,971.24%
Sep 30, 2015 6,224.30%
Jun 30, 2015 -70.70%
Mar 31, 2015 -90.39%
Dec 31, 2014 501.00%
Dec 31, 2013 -49.85%
Dec 31, 2012 18,300.00%